Stratec SE
STSEY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.67B
Close$
$0.07
98.8% downside
Current Fair Value
98.8% downsideOvervalued by 98.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.67 Billion |
|---|---|
| Enterprise Value | $1.77 Billion |
| Annual dividend | $0.14 |
| Dividend yield | 2.55% |
| Earnings per Share | $0 |
| Beta | 0.81 |
| Outstanding Shares | 303,898,550 |
Return
| Return on Equity | -0.17% |
|---|---|
| Return on Assets | -0.10% |
| Return on Invested Capital | 1.89% |
Valuation & Multiples
| P/E Ratio | -587.5 |
|---|---|
| PEG | -267.16 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 7.25 |
| Enterprise Value to EBIT | 257.96 |
| Enterprise Value to Net Income | -4491 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.5 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Stratec SE
1,403 employees
CEO: Marcus Wolfinger
Stratec SE, a company established in 1979 and headquartered in Birkenfeld, Germany (which operated as STRATEC Biomedical AG until December 2018), specializes in the development and production of advanced automation and instrumentation so...